CIK: 1761175 - Address: C/o Avista Capital Partners, 65 East 55Th Street, 18Th Floor, New York, NY 10022
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/24/20 18:10
11/20/20
ORGOOrganogenesis Holdings Inc.DEHealthDrugPharmaceutical PreparationsAvista Capital Managing Member Iv, LLCNYDTP.m144.9903029,925I
11/19/20 19:14
11/17/20
ORGOOrganogenesis Holdings Inc.DEHealthDrugPharmaceutical PreparationsAvista Capital Managing Member Iv, LLCNYDTP.m14,5013.2904,4041729,922I
3/16/20 21:47
3/12/20
ORGOOrganogenesis Holdings Inc.DEHealthDrugPharmaceutical PreparationsAvista Capital Managing Member Iv, LLCNYDTP.m2,1613.980542225,518I
11/27/19 16:17
11/26/19
ORGOOrganogenesis Holdings Inc.DEHealthDrugPharmaceutical PreparationsAvista Capital Managing Member Iv, LLCNYDTP30,0005.0006,0003224,975I
9/13/19 18:47
9/11/19
ORGOOrganogenesis Holdings Inc.DEHealthDrugPharmaceutical PreparationsAvista Capital Managing Member Iv, LLCNYDTP.m5,1565.990861518,975I
9/10/19 19:56
9/6/19
ORGOOrganogenesis Holdings Inc.DEHealthDrugPharmaceutical PreparationsAvista Capital Managing Member Iv, LLCNYDTP.m2,7835.180537318,114I
9/5/19 18:51
9/3/19
ORGOOrganogenesis Holdings Inc.DEHealthDrugPharmaceutical PreparationsAvista Capital Managing Member Iv, LLCNYDTP.m2,7984.840578317,577I
12/12/18 21:41
12/10/18
ORGOOrganogenesis Holdings Inc.DEHealthDrugPharmaceutical PreparationsAvista Capital Managing Member Iv, LLCNYTP00.0006,5397215,561I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact